by Admin | Oct 15, 2022 | CME INDIA Repository
CME INDIA Presentation based on a case by Dr. Meena Chhabra, MD, Diabetologist, New Delhi and CME INDIA Discussion. Link to Part – I: SGLT2-Inhibitors: Real World Stories, UTI, GTI & Frail Patients Part-2: Dr. A. K. Das, Diabetologist, Muzaffarpur: Doesn’t... 
by Admin | Oct 13, 2022 | CME INDIA Repository
CME INDIA Presentation based on a case by Dr. Meena Chhabra, MD, Diabetologist, New Delhi and CME INDIA Discussion. Part-1: See this Urine Report: Dr. Meena Chhabra, Diabetologist, Delhi: 50 yr., Type 2 diabetic male with history of burning in micturition.Please see... 
by Admin | Jun 9, 2022 | CME INDIA Repository
CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Based on the presentation at Diabetes India Conference 2022. Amazing changes in heart of SGLT2-Inhibitor treated... 
by Admin | Mar 2, 2022 | CME INDIA Repository
CME INDIA Presentation by Dr. N.K. Singh, MD, FICP, Director, Diabetes and Heart Research Centre, Dhanbad, Jharkhand, India. Editor, www.cmeindia.in. Adding a new patient profile in whom we can start empagliflozin in hospital. Starting SGLT2 inhibitors as soon as in... 
by Admin | Sep 15, 2021 | CME INDIA Repository
CME INDIA Presentation by Dr. N. K. Singh, MD, FICP, Director – Diabetes and Heart Research Centre, Dhanbad; Editor – CME INDIA. Black hole of cardiology, the HFpEF gets an efficacious, disease modifying treatment – NNT (Number needed to treat) of 9....